Similar articles

• High throughput screening: early successes indicate a promising future.

  Fox S, Wang H, Sopchak L, Khoury R. Fox S, et al. J Biomol Screen. 2001 Jun;6(3):137-40. doi: 10.1177/108705710100600303. J Biomol Screen. 2001. PMID: 11689109 No abstract available.
• Origin and evolution of high throughput screening.

  Pereira DA, Williams JA. Pereira DA, et al. Br J Pharmacol. 2007 Sep;152(1):53-61. doi: 10.1038/sj.bjp.0707373. Epub 2007 Jul 2. Br J Pharmacol. 2007. PMID: 17603542 Free PMC article. Review.
• Attrition in the drug discovery process: lessons to be learned from the safety pharmacology paradigm.

  Curtis MJ, Pugsley MK. Curtis MJ, et al. Expert Rev Clin Pharmacol. 2012 May;5(3):237-40. doi: 10.1586/ecp.12.22. Expert Rev Clin Pharmacol. 2012. PMID: 22697586 No abstract available.
• Expanding the HTS paradigm.

  Inglese J. Inglese J. Drug Discov Today. 2002 Sep 15;7(18 Suppl):S105-6. doi: 10.1016/s1359-6446(02)02385-1. Drug Discov Today. 2002. PMID: 12546874 No abstract available.
• New directions for drug discovery.

  Spedding M. Spedding M. Dialogues Clin Neurosci. 2006;8(3):295-301. doi: 10.31887/DCNS.2006.8.3/mspedding. Dialogues Clin Neurosci. 2006. PMID: 17117611 Free PMC article. Review.